Terms: = Breast cancer AND RALGDS, FLJ20922, 5900, ENSG00000160271, RalGEF, RGF, Q12967
26 results:
1. Association between Immediate breast Reconstruction and the Development of breast cancer-Related Lymphedema.
Jeon HB; Jung JH; Im SH; Kim YB; Chang JS; Song SY; Lew DH; Roh TS; Lee WJ; Lee DW
Plast Reconstr Surg; 2023 Feb; 151(2):214e-222e. PubMed ID: 36696309
[TBL] [Abstract] [Full Text] [Related]
2. Phylogenetic analysis of combined lobular and ductal carcinoma of the breast.
Kobayashi H; Nakai T; Nakanishi Y; Esumi M; Masuda S
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396426
[TBL] [Abstract] [Full Text] [Related]
3. Intratumoral and Peritumoral Radiomics Based on Functional Parametric Maps from breast DCE-MRI for Prediction of HER-2 and Ki-67 Status.
Li C; Song L; Yin J
J Magn Reson Imaging; 2021 Sep; 54(3):703-714. PubMed ID: 33955619
[TBL] [Abstract] [Full Text] [Related]
4. KDM4 Inhibition Targets breast cancer Stem-like Cells.
Metzger E; Stepputtis SS; Strietz J; Preca BT; Urban S; Willmann D; Allen A; Zenk F; Iovino N; Bronsert P; Proske A; Follo M; Boerries M; Stickeler E; Xu J; Wallace MB; Stafford JA; Kanouni T; Maurer J; Schüle R
Cancer Res; 2017 Nov; 77(21):5900-5912. PubMed ID: 28883001
[TBL] [Abstract] [Full Text] [Related]
5. Classification of fibroglandular tissue distribution in the breast based on radiotherapy planning CT.
Juneja P; Evans P; Windridge D; Harris E
BMC Med Imaging; 2016 Jan; 16():6. PubMed ID: 26762357
[TBL] [Abstract] [Full Text] [Related]
6. RILP suppresses invasion of breast cancer cells by modulating the activity of RalA through interaction with ralgds.
Wang Z; Zhou Y; Hu X; Chen W; Lin X; Sun L; Xu X; Hong W; Wang T
Cell Death Dis; 2015 Oct; 6(10):e1923. PubMed ID: 26469971
[TBL] [Abstract] [Full Text] [Related]
7. Quantitative photoacoustics to measure single cell melanin production and nanoparticle attachment.
Bhattacharyya K; Eshein A; Chandrasekhar A; Viator JA
Phys Med Biol; 2015 Apr; 60(8):3081-96. PubMed ID: 25803095
[TBL] [Abstract] [Full Text] [Related]
8. Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancer.
Sebestyén E; Zawisza M; Eyras E
Nucleic Acids Res; 2015 Feb; 43(3):1345-56. PubMed ID: 25578962
[TBL] [Abstract] [Full Text] [Related]
9. The role of miR-200a in mammalian epithelial cell transformation.
Becker LE; Takwi AA; Lu Z; Li Y
Carcinogenesis; 2015 Jan; 36(1):2-12. PubMed ID: 25239643
[TBL] [Abstract] [Full Text] [Related]
10. Molecular insights into the association of obesity with breast cancer risk: relevance to xenobiotic metabolism and CpG island methylation of tumor suppressor genes.
Naushad SM; Hussain T; Al-Attas OS; Prayaga A; Digumarti RR; Gottumukkala SR; Kutala VK
Mol Cell Biochem; 2014 Jul; 392(1-2):273-80. PubMed ID: 24676543
[TBL] [Abstract] [Full Text] [Related]
11. Pin1 promoter rs2233678 and rs2233679 polymorphisms in cancer: a meta-analysis.
Zhu YM; Liu JW; Xu Q; Yuan Y
Asian Pac J Cancer Prev; 2013; 14(10):5965-72. PubMed ID: 24289610
[TBL] [Abstract] [Full Text] [Related]
12. RASSF2 hypermethylation is present and related to shorter survival in squamous cervical cancer.
Guerrero-Setas D; Pérez-Janices N; Blanco-Fernandez L; Ojer A; Cambra K; Berdasco M; Esteller M; Maria-Ruiz S; Torrea N; Guarch R
Mod Pathol; 2013 Aug; 26(8):1111-22. PubMed ID: 23542458
[TBL] [Abstract] [Full Text] [Related]
13. [Methods to increase participation in cancer screening programmes].
Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
[TBL] [Abstract] [Full Text] [Related]
14. RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency.
Buhmeida A; Merdad A; Al-Maghrabi J; Al-Thobaiti F; Ata M; Bugis A; Syrjänen K; Abuzenadah A; Chaudhary A; Gari M; Al-Qahtani M; Dallol A
Anticancer Res; 2011 Sep; 31(9):2975-81. PubMed ID: 21868547
[TBL] [Abstract] [Full Text] [Related]
15. First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations.
Iwamoto T; Lee JS; Bianchini G; Hubbard RE; Young E; Matsuoka J; Kim SB; Symmans WF; Hortobagyi GN; Pusztai L
Breast Cancer Res Treat; 2011 Nov; 130(1):155-64. PubMed ID: 21833625
[TBL] [Abstract] [Full Text] [Related]
16. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract] [Full Text] [Related]
17. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
Oberst MD; Beberman SJ; Zhao L; Yin JJ; Ward Y; Kelly K
BMC Cancer; 2008 Jul; 8():189. PubMed ID: 18597688
[TBL] [Abstract] [Full Text] [Related]
18. Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: a model for identifying candidate breast-tumor suppressors.
Zientek-Targosz H; Kunnev D; Hawthorn L; Venkov M; Matsui S; Cheney RT; Ionov Y
Mol Cancer; 2008 Jun; 7():51. PubMed ID: 18534021
[TBL] [Abstract] [Full Text] [Related]
19. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract] [Full Text] [Related]
20. Choline kinase: an important target for cancer.
Janardhan S; Srivani P; Sastry GN
Curr Med Chem; 2006; 13(10):1169-86. PubMed ID: 16719778
[TBL] [Abstract] [Full Text] [Related]
[Next]
